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Abstract: The N-methyl-d-aspartate receptor is an important mediator of the
behavioral effects of ethanol in the central nervous system. Previous studies
have demonstrated sites in the third and fourth membrane-associated (M)
domains of the N-methyl-d-aspartate receptor NR2A subunit that influence
alcohol sensitivity and ion channel gating. We investigated whether two of
these sites, Phe-637 in M3 and Met-823 in M4, interactively regulate the
ethanol sensitivity of the receptor by testing dual substitution mutants at
these positions. A majority of the mutations decreased steady-state
glutamate EC50 values and maximal steady-state to peak current ratios
(Iss/Ip), whereas only two mutations altered peak glutamate EC50 values.
Steady-state glutamate EC50 values were correlated with maximal glutamate
Iss/Ip values, suggesting that changes in glutamate potency were attributable
to changes in desensitization. In addition, there was a significant interaction
between the substituents at positions 637 and 823 with respect to glutamate
potency and desensitization. IC50 values for ethanol among the mutants
varied over the approximate range 100–325 mm. The sites in M3 and M4
significantly interacted in regulating ethanol sensitivity, although this was
apparently dependent upon the presence of methionine in position 823.
Molecular dynamics simulations of the NR2A subunit revealed possible binding
sites for ethanol near both positions in the M domains. Consistent with this
finding, the sum of the molecular volumes of the substituents at the two
positions was not correlated with ethanol IC50 values. Thus, there is a
functional interaction between Phe-637 and Met-823 with respect to
glutamate potency, desensitization, and ethanol sensitivity, but the two
positions do not appear to form a unitary site of alcohol action.

Ethanol is unusual among the major drugs of abuse in that it
acts only at high concentrations (in the millimolar range) and that it
acts on multiple targets in the central nervous system. For the greater
part of the last century, ethanol was generally believed to produce its
effects on central nervous system function via nonspecific actions on
neuronal lipids, but it is now well accepted that the biologically
important actions of ethanol are due to its interactions with proteins
(1, 2). Of these proteins, the N-methyl-d-aspartate (NMDA)2 receptor
is among the most important target sites of ethanol in the central
nervous system. At relevant concentrations, ethanol inhibits ionic
current (3), synaptic potentials (4), Ca2+ influx (5, 6), and
neurotransmitter release (7) mediated by NMDA receptors. Studies of
the mechanism of this inhibition have shown that it does not involve
competitive inhibition at the glutamate or glycine binding sites (7–12)
or interaction with sites for other allosteric modulators (8, 12) or open
channel block (13, 14) but that it involves changes in NMDA receptor
gating, notably mean open time and opening frequency (13, 14).
Thus, ethanol appears to inhibit NMDA receptors via low affinity
interactions with sites that regulate ion channel gating. Although sites
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in the intracellular C-terminal domain may modulate both ethanol
sensitivity of the NMDA receptor (15) and ion channel gating (16–19),
this domain does not contain the site of ethanol action, since removal
of this region of the protein does not decrease ethanol inhibition of the
receptor (20).
In a previous study, Ronald et al. (21) demonstrated that a
phenylalanine residue (Phe-639) in the third membrane-associated (M)
domain of the NMDA receptor NR1 subunit influences alcohol
sensitivity and shows some characteristics of a site of alcohol action. A
previous study from this laboratory (22) identified a methionine
residue (Met-823) in the M4 domain of the NMDA receptor NR2A
subunit that also influences alcohol sensitivity and that fulfills some of
the criteria for a site of alcohol action. The methionine in M4, however,
also profoundly affects the gating behavior of the ion channel (23). We
have recently shown (24) that the cognate position of NR1(Phe-639) in
the NR2A subunit, Phe-637, also regulates alcohol sensitivity as well as
desensitization and agonist potency. Studies in γ-aminobutyric acidA
and glycine receptors have demonstrated residues in transmembrane
domains 2 and 3 that form sites of alcohol and anesthetic action (25,
26). These residues appear to line opposite sides of a binding cavity
for alcohol and various anesthetics (27), which modulate γaminobutyric acidA and glycine receptor ion channel gating (28) by
occupying a critical volume (29–33). In the present study, we
investigated whether Phe-637 and Met-823 in the NR2A subunit could
form a unitary binding site analogous to that found in γ-aminobutyric
acidA and glycine receptors. We report here that these sites appear to
functionally interact in regulation of NMDA receptor function and
ethanol sensitivity, but they do not appear to form a common site of
ethanol action.

Experimental Procedures
Materials—Ethanol (95%, prepared from grain) was obtained
from Aaper Alcohol & Chemical Co. (Shelbyville, KY), and all other
drugs were obtained from Sigma.
Site-directed Mutagenesis and Transfection—Site-directed
mutagenesis in plasmids containing NR2A subunit cDNA was
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performed using the QuikChange kit (Stratagene), and all mutants
were verified by double strand DNA sequencing. Human embryonic
kidney 293 (HEK293) cells were transfected with NR1–1a, NR2A, and
green fluorescent protein at a ratio of 2:2:1 using the calcium
phosphate transfection kit (Invitrogen). In electrophysiological
experiments, 100 μm ketamine and 200 μm d-l,2-amino-5phosphonovaleric acid were added to the culture medium. Cells were
used in whole cell patch clamp experiments 15–48 h after transfection.
Electrophysiological Recording—Whole cell patch clamp
recording was performed at room temperature using an Axopatch 1D
or Axopatch 200B (Axon Instruments) amplifier. In ethanol
concentration-response experiments, electrodes with open tip
resistances of 3–8 megaohms were used. After establishing whole cell
mode, series resistances of 5–15 megaohms were obtained. In
glutamate concentration-response experiments, thin wall glass
capillaries were used to pull electrodes with open tip resistances of 1–5
megaohms and series resistances of 2–7 megaohms. In all
experiments, series resistance was compensated by 80%. Cells were
voltage-clamped at –50 mV and superfused in an external recording
solution containing 150 mm NaCl, 5 mm KCl, 0.2 mm CaCl2, 10 mm
HEPES, 10 mm glucose, and 20 mm sucrose. In glutamate
concentration-response experiments, the external solution contained
EDTA (10 μm) to eliminate the fast component of apparent
desensitization due to high affinity Zn2+ inhibition (34). The external
solution pH was adjusted to 7.4 with NaOH. The intracellular recording
solution contained 140 mm CsCl, 2 mm Mg4ATP, 10 mm 1,2-bis(2aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid, and 10 mm HEPES.
The intracellular solution pH was adjusted to 7.2 with CsOH. Solutions
of agonists and ethanol were applied to cells using a stepper motordriven solution exchange apparatus (Warner Instruments, Inc.) and
600-μm inner diameter square glass tubing. Ethanol concentrations
greater than 500 mm tended to disrupt the gigaohm seal; thus, 500
mm was the maximum concentration used in ethanol concentrationresponse experiments. In glutamate concentration-response
experiments, cells were lifted off the surface of the dish to increase the
speed of the solution exchange. We have shown previously that under
these conditions, 10–90% rise times for solution exchange are ∼1.5
ms (23). Concentration-response data were filtered at 2 kHz (8-pole
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Bessel) and acquired at 5 kHz on a computer by using a DigiData
interface and pClamp software (Axon Instruments).
Molecular Modeling and Molecular Dynamics (MD) Simulations—
A model of the transmembrane region of the NR2A subunit of the
NMDA receptor was built by homology modeling with InsightII
software from Biosym (now Accelrys; San Diego, CA). Aquaporin
(Protein Data Bank code 1fqy) served as the template for modeling,
since the arrangement of its helices with respect to the M2 segment
was the best of several candidates that were considered. The aminoterminal domain and the S2 ligand-binding domain of NR2A were
omitted from the model. A segment between the end of M1 and the
start of M2 had no counterpart in aquaporin and was created as a helix
and loop. The initial model was subjected to energy minimization with
a total of 300 iterations of the steepest descent and conjugate
gradient algorithms. The AMBER force field was used for all energy
calculations. The minimized structure then served as a template for
further refinement of the model. The tilt of the M3 helix was adjusted
manually to optimize packing with the other transmembrane
segments. In addition, residues along M1 and M3 were shifted one or
two positions to account for accessibility data (35, 36). Steric clashes
were corrected, and the structure was further minimized.
Binding of ethanol to the model NR2A subunit was evaluated by
adapting the general Monte Carlo simulation method of Clark et al.
(37). For the MD simulation, the NR2A subunit was solvated with a
3.5-Å layer of ethanol, which included 122 solvent molecules. The
NR2A subunit was fixed during the calculations (AMBER force field):
2,000 steps (1 fs each) of equilibration and 134,000 steps in the
trajectory at 323 K. Snapshots were saved every 1,000 steps. Most of
the ethanol solvent (nearly 90%) dispersed from the protein over the
course of the simulation; 15 molecules remained bound at the end of
the run.
Data Analysis—In concentration-response experiments, IC50 or
EC50 and n (slope factor) were calculated using the equation, y =
Emax/1 + (IC50 or EC50/x)n, where y represents the measured current
amplitude, x is concentration, n is the slope factor, and Emax is the
maximal current amplitude. Statistical differences among
concentration-response curves were determined by comparing log
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transformed EC50 or IC50 values from fits to data obtained from
individual cells using ANOVA followed by the Dunnett's and TukeyKramer tests. Comparisons among mean values of log EC50, IC50, or
Iss/Ip for the various mutants were made using correlation analysis,
and testing for linear relations of these values to amino acid molecular
volume (determined as described previously (23)) was performed
using linear regression analysis.

Results
Effects of Dual Mutations at Phe-637 and Met-823 on Glutamate
Potency and Desensitization—In order to investigate whether the sites
Phe-637 in the M3 domain and Met-823 in the M4 domain of the NR2A
subunit might interactively regulate the function of the receptor, we
constructed and tested a series of mutants incorporating dual
substitutions at these positions. Because only hydrophobic amino acids
were tolerated at the Met-823 position, we chose to test combinations
of alanine, tryptophan, and the wild type amino acids methionine and
phenylalanine at these sites. Fig. 1 shows that all combinations of
these amino acids that were tested at Phe-637 and Met-823 yielded
functional receptors and that both glutamate potency and
desensitization were altered in some of the mutants. Concentrationresponse curves for glutamate activation of peak and steady-state
current in the series of mutants were parallel, indicating that none of
the mutations significantly altered the Hill coefficient (p > 0.05;
ANOVA). We have previously reported that individual mutations at
either Phe-637 or Met-823 can alter glutamate EC50 values (23, 24).
Of six mutant subunits containing dual substitutions at Phe-637 and
Met-823, none exhibited altered EC50 values for glutamate activation of
peak current, whereas four had decreased EC50 values for glutamate
activation of steady-state current (Fig. 2; p < 0.0001; ANOVA). In
addition, macroscopic desensitization was increased in the majority of
these mutants. Values of maximal Iss/Ip for currents activated by 300
μm glutamate in lifted cells were in the range 0.04–0.4 for most of the
mutants, compared with a value of 0.66 in the wild type receptor (p <
0.0001; ANOVA). Previous results from our laboratory have
demonstrated that for single substitution mutants at NR2A(Met-823),
observed changes in steady-state glutamate EC50 were attributable to
changes in desensitization (23). In the present study, we found that
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there was a significant correlation between steady-state glutamate log
EC50 and maximal Iss/Ip for the series of mutants (R2 = 0.349, p <
0.05).

FIGURE 1.
Glutamate-activated currents in NR2A(Phe-637/Met-823) mutant subunits. A,
records are currents activated by 1, 10, and 100 μm glutamate in the presence of 50
μm glycine in lifted cells expressing NR1 and wild type NR2A subunits (F/M) or NR2A
subunits containing various mutations at Phe-637 and Met-823. One-letter amino acid
codes are used. B and C, concentration-response curves for glutamate activation of
peak (B) and steady-state (C) current in lifted cells expressing various dual site
substitution mutations at NR2A(Phe-637/Met-823). Data are means ± S.E.; error bars
not visible were smaller than the size of the symbols. Curves shown are the best fits to
the equation given under “Experimental Procedures.” The fit for the wild type NR2A
subunit is shown as a dashed line. Plots for single-site mutations are not shown.
Values for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. 24.
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FIGURE 2.
Mutations at NR2A(Phe-637/823) can alter glutamate potency and
desensitization. A and B, average EC50 values for glutamate activation of peak (A)
and steady-state (B) current in lifted cells expressing NR1 and wild type NR2A
subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met823. *, EC50 values that are significantly different from that for wild type NR1/NR2A
subunits (*, p < 0.05; **, p < 0.01; ANOVA followed by Dunnett's test). Results are
means ± S.E. of 5–8 cells. C, average values of maximal steady-state to peak current
ratio (Iss/Ip) in lifted cells coexpressing NR1 and wild type NR2A subunits (F/M) or
NR2A subunits containing various mutations at Phe-637 and Met-823. Currents were
activated by 300 μm glutamate in the presence of 50 μm glycine and 10 μm EDTA. *,
values that differed significantly from that for wild type NR1a/NR2A subunits (**, p <
0.01; ANOVA followed by Dunnett's test). Results are means ± S.E. of 5–8 cells. D,
graph plots values of maximal Iss/Ip versus glutamate log EC50 for steady-state current
in the series of mutants. Maximal Iss/Ip was significantly correlated with glutamate log
EC50 for steady-state (R2 = 0.349, p < 0.05) but not peak (R2 = 0.0515, p > 0.05;
results not shown) current. The line shown is the least-squares fit to the data. Values
for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. 24.

Effects of Dual Mutations at Phe-637 and Met-823 on Ethanol
Sensitivity—We next evaluated the ethanol sensitivity of receptors
containing various mutations at Phe-637 and Met-823 of the NR2A
subunit by performing concentration-response analysis. All of the
mutant receptors tested were inhibited by ethanol (Fig. 3).
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Concentration-response curves for the mutants were essentially
parallel to each other, but ethanol IC50 values among the mutants
varied considerably (p < 0.0001; ANOVA). The largest change in
ethanol sensitivity was observed in the NR2A(F637W) mutant;
significant differences from the wild type value were also observed for
the M823W mutant and for all mutants involving dual substitution of
alanine and tryptophan. It is possible that changes in receptor
desensitization could differentially alter ethanol sensitivity of peak and
steady-state current. Previous results from our laboratory (22, 24),
however, have shown that ethanol inhibition of peak and steady-state
current does not differ in single substitution mutants at Phe-637 or
Met-823 of the NR2A subunit. In the present study, ethanol inhibition
of peak and steady-state current did not differ in F637A/M823W or
F637W/M823W subunits, the most highly desensitizing of the dual site
mutants (repeated measures ANOVA, p > 0.05; results not shown).

FIGURE 3.
Mutations at NR2A(Phe-637/Met-823) can alter NMDA receptor ethanol
sensitivity. A, records are currents activated by 10 μm glutamate and 50 μm glycine
and their inhibition by 100 mm ethanol (EtOH) in cells expressing NR1 and wild type
NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and
Met-823. B, concentration-response curves for ethanol inhibition of glutamateJournal of Biological Chemistry, Vol. 283, No. 13 (March 28, 2008): pg. 8250-8257. DOI. This article is © American Society
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activated current in cells expressing various dual site substitution mutations at
NR2A(Phe-637/Met-823). Data are means ± S.E. of 5–12 cells; error bars not visible
were smaller than the size of the symbols. Curves shown are the best fits to the
equation given under “Experimental Procedures.” The fit for the wild type NR2A
subunit is shown as a dashed line. Plots for single-site mutations are not shown. C,
average IC50 values for ethanol inhibition of glutamate-activated current in cells
expressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing
various mutations at Phe-637 and Met-823. *, EC50 values that are significantly
different from that for wild type NR1/NR2A subunits (**, p < 0.01; ANOVA followed by
Dunnett's test). Results are means ± S.E. of 5–12 cells. Values for wild type,
NR2A(F637A), and NR2A(F637W) are from Ref. 24; values for NR2A(M823A),
NR2A(M823F), and NR2A(M823W) are from Ref. 22.

Relation of Ethanol Sensitivity to Receptor Function in Dual
Mutations at Phe-637 and Met-823—It is possible that the changes in
ethanol sensitivity we observed in the series of mutants tested might
be linked to changes in agonist potency and desensitization.
Correlation analysis revealed that ethanol IC50 values were significantly
negatively correlated with values for glutamate steady-state IC50 (Fig.
4; R2 = 0.501, p < 0.05), but not glutamate peak IC50 (R2 = 0.327; p
> 0.05) or maximal steady-state to peak current ratio (R2 = 0.111; p
> 0.05). Upon inspection of the graph for the latter, it appeared that
the value for the NR2A(F637W) mutant subunit was an outlier due to
the dissociation between steady-state glutamate EC50 and maximal
Iss/Ip value in this mutant. When the value for the NR2A(F637W)
mutant was excluded from the analysis, a highly significant negative
correlation was obtained between maximal Iss/Ip and ethanol IC50 (R2 =
0.691, p < 0.001).
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FIGURE 4.
Ethanol sensitivity of NMDA receptors containing NR2A(Phe-637/Met-823)
mutant subunits is related to glutamate potency and desensitization. A, the
graph plots values of log glutamate EC50 for peak (closed circles) and steady-state
(open circles) current versus log ethanol IC50. Glutamate EC50 was significantly
negatively correlated with log ethanol IC50 for steady-state (R2 = 0.501, p < 0.01;
dashed line) but not peak (R2 = 0.327, p > 0.05; solid line) current. The lines shown
are the least-squares fits to the data. B, the graph plots values of maximal Iss/Ip
versus log ethanol IC50. These variables were not significantly correlated when the
value for the NR2A(F637W) mutant was included in the analysis (R2 = 0.111; p >
0.05; solid line) but were significantly negatively correlated when this value was
excluded from the analysis (R2 = 0.691; p < 0.001; dashed line). Values for wild type,
NR2A(F637A), and NR2A(F637W) are from Ref. 24; values for NR2A(M823A),
NR2A(M823F), and NR2A(M823W) are from Ref. 22.

Interactions of Phe-637 and Met-823 in Regulation of Glutamate
Potency, Desensitization, and Ethanol Sensitivity—The effects of
mutations at Phe-637 and Met-823 on glutamate EC50 and maximal
Iss/Ip values we observed could indicate that these sites interact with
each other in some manner to regulate receptor function. To
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investigate this possibility, we constructed interaction plots and
analyzed the data using two-way ANOVA (Fig. 5). Although only 2 of
the 11 mutations significantly altered the glutamate peak EC50 value,
we observed highly significant effects on glutamate peak EC50 of the
residues at each position individually (p < 0.0001; ANOVA) as well as
a highly significant interactive effect (p < 0.0001; ANOVA). In
addition, we observed significant effects on glutamate steady-state
EC50 of the residue at each individual position (p < 0.0001; ANOVA),
and a significant interaction between the two positions (p < 0.0001;
ANOVA). In contrast, maximal Iss/Ip values were altered by mutations
at position 823 (p < 0.0001; ANOVA) but not 637 (p > 0.05; ANOVA);
nevertheless, mutations at both sites interactively regulated maximal
Iss/Ip (p < 0.0001; ANOVA).

FIGURE 5.
Positions 637 and 823 in the NR2A subunit interactively regulate NMDA
receptor function and ethanol sensitivity. A and D, the graphs plot EC50 for
glutamate activation of peak (A) and steady-state (B) current, maximal Iss/Ip (C), and
ethanol IC50 (D) versus the substituent at position 823 for the series of mutants at
NR2A(Phe-637/Met-823). Although the substituent at 637 did not by itself affect
maximal Iss/Ip values (p > 0.05; ANOVA), there were highly significant effects of the
substituents at 637 and 823 individually on all other measures (p < 0.0001; ANOVA),
and highly significant interactions between the substituents at 637 and 823 on all
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measures (p < 0.0001; ANOVA). Note the departure from parallelism due to the
values for subunits containing methionine at position 823.

We also tested whether the substituents at Phe-637 and Met823 could interactively regulate ethanol sensitivity. Ethanol IC50 was
highly dependent upon the residue at each position individually (p <
0.0001; ANOVA), and the analysis also revealed a highly significant
interaction between the sites in M3 and M4 in regulation of ethanol
IC50 (p < 0.0001; ANOVA). This interaction was dependent upon the
presence of the wild type residue methionine at position 823 in M4,
since it was no longer significant if the values for subunits with
methionine at 823 were excluded from the analysis (p > 0.05;
ANOVA).
Relation of Molecular Volume of Substituents at Phe-637 and
Met-823 to NMDA Receptor Ethanol Sensitivity—In the substitution
mutants at sites Phe-637 and Met-823 in the NR2A subunit, the
observation that the substituent at one position could alter the effects
of substituents at the other position on ethanol sensitivity of the
receptor could indicate that these residues physically interact with
each other. If these sites lined opposite sides of an ethanol binding
cavity and if ethanol acted via volume occupation of this pocket, then
one would predict that there should be a significant linear relation
between ethanol IC50 and the combined molecular volume of the
amino acid side chains at the two sites. However, no such relation was
observed (Fig. 6; R2 = 0.0229; p > 0.05).
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FIGURE 6.
Combined molecular volume at 637 and 823 in the NR2A subunit is not
related to ethanol sensitivity. The graph plots ethanol IC50 versus the sum of the
molecular volumes (in Å3) of the substituents at positions 637 and 823 for the series
of mutants at NR2A(Phe-637/Met-823). There was not a significant linear relation
between ethanol sensitivity and molecular volume at the two sites (R2 = 0.0229, p >
0.05).

Molecular Dynamics Simulation of Ethanol Binding to the M
Domains of the NMDA Receptor NR2A Subunit—To determine whether
ethanol is likely to bind at sites near Phe-637 and Met-823, we
constructed a model of the M domains of the NMDA receptor NR2A
subunit and performed MD simulations. Phe-637 and Met-823 were
13–14 Å apart and appeared to be most closely oriented toward the
M2 and M3 domains. The model NR2A subunit was soaked with
ethanol solvent to saturate possible alcohol binding sites. MD
simulations were then run in which ethanol was allowed to dissociate
from these binding sites over the course of the trajectory. Solvent
molecules that are the last to leave represent the strongest
interactions. In this model (Fig. 7), ethanol bound to a number of sites
throughout the M domains, including Phe-637 and Met-823. Although
the MD simulation did not permit precise quantitation of binding
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affinity, the affinity of ethanol for Phe-637 and Met-823 was in the top
10% of all sites.

FIGURE 7.
A molecular model of the NR2A subunit M domains showing putative binding
sites for ethanol at positions 637 and 823. A model of the M domains of the NR2A
subunit was derived by homology modeling and is depicted as a ribbon structure.
Following solvation with ethanol, MD simulations were run in which the ethanol was
allowed to diffuse away to identify the most probable binding sites. The M2 segment is
highlighted in purple, and Met-825 and Phe-637 are shown in light blue. Molecules of
the ethanol solvent are white. Note that two ethanol molecules (light green) remain
tightly associated with Phe-637 and Met-823.

Discussion
We have previously shown that Phe-637 in M3 and Met-823 in
M4 of the NR2A subunit influence both receptor function and alcohol
sensitivity (22–24). In the present study, we observed that the
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substituent at either of these positions can alter the influence of the
substituent at the other position on both receptor function (agonist
potency and desensitization) and ethanol sensitivity of the receptor. A
direct interaction, such as hydrogen or hydrophobic bonding, between
the amino acid side chains at positions 637 and 823, however, appears
unlikely. The functional interaction depended upon the inclusion of the
mutant containing the wild type residue, methionine, at position 823
and tryptophan at position 637, because when the value for this
mutant was removed, the interaction plots were essentially parallel.
We have previously reported that this mutant, NR2A(F637W), showed
a marked decrease in the glutamate EC50 values for both peak and
steady-state current, apparently due to changes in gating (24).
Substitution of alanine, phenylalanine, or tryptophan at position 823
reduced, or in some cases eliminated, this effect. This observation is
difficult to reconcile with a direct interaction between the side chains at
these positions. A more probable explanation is that when the wild
type methionine is present at position 823, it may interact with other
groups in its environment in a manner that places a conformational
constraint on the M4 domain, which in turn restricts the conformation
of the other M domains. This conformational restriction could then
allow tryptophan substitution at position 637 to produce a substantial
change in gating. Substitution of methionine with a hydrophobic amino
acid at 823 may release this constraint, diminishing the effect of
tryptophan at 637. Recent evidence from a study using cysteine
substitution in NR1/NR2C NMDA receptors (41) is also not consistent
with an interaction between positions 637 and 823. In this study, the
location of the amino acids corresponding to Phe-637 and Met-823 in
the NR1 and NR2C subunits differed by 6–10 positions within the plane
of the membrane and thus are not likely to be in close proximity to
each other. The topology of the M domains derived from homology
modeling in the present study is also consistent with the view that
Phe-637 and Met-823 do not directly interact. In this model, Phe-637
and Met-823 are ∼14 Å apart with the M2 loop sandwiched in between.
In γ-aminobutyric acidA and glycine receptors, amino acid
substitutions at critical positions in transmembrane domains 2 and 3
can alter alcohol and anesthetic potency (25, 26). These residues
appear to form opposite sides of a cavity that binds alcohol and
various anesthetics (27). The accessibility and dimensions of this
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cavity change during ion channel gating (38, 39), and occupation of
the cavity by an alcohol or anesthetic molecule alters gating of the ion
channel (28, 38). The potency of various alcohols and anesthetics for
enhancing agonist-activated currents in these receptors is positively
correlated with the molecular volume of the alcohol or anesthetic and
negatively correlated with the molecular volume of the amino acid side
chain (29–33). The occupation of a critical volume in this cavity by the
alcohol or anesthetic molecules is thus thought to be responsible for
their modulation of receptor function. If there were a similar cavity
between the M3 and M4 domains of the NR2A subunit incorporating
positions 637 and 823 and if ethanol acted by occupying a critical
volume to destabilize a conformational change in this cavity associated
with ion channel gating, one would also predict that the molecular
volume of the substituents at positions 637 and 823 would be
correlated with ethanol potency. Although this is the case for
substitutions at position 823 (22), there is a negative correlation with
ethanol potency for substitutions at position 637 (24). In the present
study, there was no relation between the sum of the molecular
volumes of the substituents and ethanol potency, which may indicate
that the opposing effects of molecular volume at positions 637 and
823 negated each other. The results obtained in MD simulations were
also not consistent with a single site of ethanol action formed by
positions 637 and 823. Although both Phe-637 and Met-823 contribute
to ethanol binding sites in this model, these residues are separated by
an estimated distance of 13–14 Å, which means they are not
sufficiently close to form a common binding site for a single ethanol
molecule. Thus, it is more likely that Phe-637 and Met-823 form
separate sites of alcohol action.
In previous studies from this laboratory, ethanol potency was
not related to measures of desensitization for single-site substitution
mutants at NR2A(Phe-637) (24) or NR2A(Met-823) (22). Ethanol
potency and maximal glutamate Iss/Ip were not correlated in the
present study for the entire panel of substitution mutants at both
positions but were significantly negatively correlated when the value
for the F637W mutant was excluded. Thus, in mutants other than
NR2A(F637W), ethanol potency decreased with increases in
desensitization. The observation that the correlation was vitiated by
the inclusion of the NR2A(F637W) mutant, which exhibited low
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desensitization and low ethanol potency, argues against modulation of
desensitization as the critical factor in the action of ethanol.
Nevertheless, in light of the observations of an apparent trend toward
a correlation of ethanol sensitivity and desensitization in our previous
study (22) and the stabilization of desensitization by ethanol in a nonNMDA glutamate receptor (40), the results of the present study raise
the possibility that desensitization may contribute to the action of
ethanol on NMDA receptors.
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